Evidence map›Paper›PMID 35039057›Full record

ArticleTrials2022

An enhanced participant information leaflet and multimedia intervention to improve the quality of informed consent to a randomised clinical trial enrolling people living with HIV and obesity: a protocol for a Study Within A Trial (SWAT).

Lydia O'Sullivan, Stefano Savinelli, Stephen O'Hare, Sinéad Holden, Ciara McHugh, Patrick Mallon, Peter Doran

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT04174755. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04174755 narecruiting

Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV

Ran2022Enrolled80Registered outcomes10Posted comparisons0ConditionsHIV-1-infection, ObesityArmsSemaglutide Injectable Product, Standard of care
Open the trial in the graph
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lydia O'SullivanSchool of Medicine, University College Dublin, Dublin 4, Ireland. lydia.osullivan@ucdconnect.ie.ORCID http://orcid.org/0000-0002-7131-5048
Stefano SavinelliSaint Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
Stephen O'HareHIV Ireland, Eccles Street, Dublin 7, Ireland.
Sinéad HoldenSchool of Medicine, University College Dublin, Dublin 4, Ireland.
Ciara McHughClinical Research Centre, Mater Misericordiae University Hospital, School of Medicine, University College Dublin, Dublin 4, Ireland.
Patrick MallonSaint Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
Peter DoranSchool of Medicine, University College Dublin, Dublin 4, Ireland.

Funding

Health Research Board-Trials Methodology Research Network HRB-TMRN-2017-1
6 · The paper itself

Abstract

backgroundIt is the investigator's responsibility to communicate the relevant information about a clinical trial to participants before they provide informed consent to take part. Systematic reviews indicate that participants often have a poor understanding of the concepts which are key to ensuring valid informed consent, such as randomisation and risks/discomforts. Paper-based participant information leaflets and informed consent forms (PIL/ICFs) are becoming longer and are often too complex for many participants. Multimedia interventions and enhanced PIL/ICFs have been trialled in an attempt to improve participants' understanding of various aspects of research studies. However, there is insufficient empirical evidence to determine how effective such interventions are. This protocol describes a study to evaluate whether an enhanced PIL/ICF and website help research participants to understand important information about a human immunodeficiency virus (HIV) randomised clinical trial.

methodsThis Study Within A Trial (SWAT) is a prospective, multi-centre, randomised, controlled, parallel-group study embedded in a host clinical trial. The host trial (the SWIFT trial; EudraCT: 2019-002314-39) is a prospective, multi-centre, randomised, open-label, controlled trial investigating if semaglutide along with dietary advice assists individuals with HIV and obesity to lose weight, compared to dietary advice alone. For the SWAT, participants will be randomised in a 1:1 ratio to either the control (standard PIL/ICF) or the intervention (an enhanced PIL/ICF and a website which includes animations). The enhanced PIL/ICF and website were developed in line with the guidance from organisations which promote plain English and accessible public-facing materials in conjunction with HIV Ireland, a HIV advocacy organisation, and our previous work on consent documents. The primary outcome of the SWAT is the quality of informed consent, assessed by a validated comprehension test-the modified Deaconess Informed Consent Comprehension Test (DICCT). The DICCT will be administered within 48 h of consent to the host trial. The secondary is recall, measured by the modified DICCT questionnaire scores 2 weeks post-consent to the host trial. DISCUSSION: The results of this SWAT will add to the methodological evidence base on the use of multimedia to improve the quality of informed consent to randomised clinical trials.

trial registrationClinicalTrials.gov NCT04174755 . EudraCT 2019-002314-39. SWAT 160, Northern Ireland Hub for Trials Methodology Research SWAT repository (Clarke M, et al., Trials. 16:P209, 2015).

Indexed as

HIV InfectionsMultimediaHumansInformed ConsentMulticenter Studies as TopicObesityProspective StudiesRandomized Controlled Trials as TopicClinical trialsInformed consentMultimediaParticipant information leafletsPatient and public involvement (PPI)Study Within A Trial (SWAT)

Identifiers

PMID35039057
PMCPMC8762861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.